Oslo University Hospital, Oslo, Norway
Mari Fjørtoft Ystgaard , Tor Åge Myklebust , Jørgen Smeby , Inger Kristin Larsen , Tormod Kyrre Guren , Elin H. Kure , Kjell Magne Tveit , Bengt Glimelius , Marianne G. Guren , Julian Hamfjord
Background: The incidence of colorectal cancer (CRC) has decreased or stabilized in most high-income countries, but an alarming increase is observed in younger adults. Norway has high CRC incidence, which increased until the past two decades, then stabilized. A national screening program started in 2022; hence, this study is on a screening-naïve population. We aim to describe up-to-date incidence patterns of CRC, with emphasis on age-specific differences in tumor site and morphology. Methods: We extracted data on all CRC cases diagnosed 1993 to 2022 from the Cancer Registry of Norway, with completeness estimated to be >99%. Data was stratified by age groups (20-49, 50-74, and ≥75), sex, primary tumor location and morphology. Age-adjusted incidence rates were calculated using Stata 17 and analyzed using Joinpoint regression to provide annual percentage change (APC) and average annual percentage change (AAPC) of incidence rates. Results: There were 107 524 cases eligible for analysis. In the age group ≥75, overall incidence increased (AAPC 0.8), mainly caused by right-sided colon cancer (RCC), which increased until 2016 (APC 2.5), followed by a slight decrease (APC -0.9). The age group 50-74 had stable incidence (AAPC -0.2). Incidence in the age group 20-49 increased (AAPC 1.3), caused by left-sided colon cancer (LCC) and rectal cancer (RC). When stratifying on morphology, incidence of mucinous carcinomas was stable (AAPC -0.6), approx. 10% of all CRC cases. Neuroendocrine neoplasms (NEN) increased in all age groups (AAPC 4.2), accounting for only 1.4% of all CRC cases; but contributed somewhat to the overall incidence in age group 20-49, in particular RC where 8.8% of cases were NEN. In the age group 20-49, adenocarcinomas had an AAPC of 1.4, mucinous carcinomas -0.8, and NEN 4.1. Conclusions: We found an increasing incidence of CRC in the youngest (<50) and elderly (≥75). LCC and RC incidence increased in the youngest age group, still increasing up until 2022. In contrast, the increase in the elderly was mostly due to RCC. Different incidence patterns of primary tumor locations in younger and older age groups may imply differences in etiology and prognosis, different biological features and possibly therapeutic implications.
Age-standardized incidence (ASR) per 100 000 and AAPC for all CRC 1993-2022 stratified for age groups and primary tumor site. | ||||
---|---|---|---|---|
Age/site | ASR 1993 | ASR 2022 | AAPC (95% CI) | AAPC male/female |
20-49 RCC | 2.1 | 1.9 | 0.1 (-0.5, 0.6) | 0.2/-0.1 |
LCC | 1.8 | 4.5 | 2.0* (1.5, 2.4) | 2.3*/1.6* |
RC | 2.6 | 4.6 | 1.8* (1.2, 2.3) | 2.1*/1.4* |
50-74 RCC | 38.2 | 40.0 | 0.1 (-0.2, 0.5) | 0.2/-0.2 |
LCC | 42.3 | 45.3 | 0.0 (-0.5, 0.5) | 0.2/-0.2 |
RC | 46.4 | 41.5 | -0.4* (-0.6, -0.2) | -0.4*/-0.4* |
≥75 RCC | 121.3 | 224.6 | 1.8* (1.3, 2.2) | 1.5*/2.0* |
LCC | 109.6 | 114.4 | 0.4 (-0.1, 0.9) | 0.2/0.3 |
RC | 111.6 | 100.1 | -0.4* (-0.7, -0.1) | -0.6*/-0.7* |
**AAPC significantly different from zero, p<0.05.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2023 ASCO Annual Meeting
First Author: Chi Mai Nguyen
2023 ASCO Gastrointestinal Cancers Symposium
First Author: Joanna El Hajj
2023 ASCO Annual Meeting
First Author: Isabelle Franklin
2024 ASCO Quality Care Symposium
First Author: Kimberley Lynn Newcomer